Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 41

Trial Status

Completed2
Recruiting1
Terminated3

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT03537547Phase 4Terminated
Combinatorial Pharmacogenomics Testing in Treatment-NaĂ¯ve Major Depressive Disorder
DepressionDepression, UnipolarDepressive Disorder+2 more
PrincipalinvestigatorStart date: 2018-05-04
NCT02942368Phase 1Terminated
Adaptive tDCS for Treatment-Resistant MDD
Depressive Disorder, Treatment-Resistant
PrincipalinvestigatorStart date: 2017-04-14
NCT00320372Completed
Treatment-Resistant Depression Registry
Major Depressive Disorder
Principalinvestigator
NCT01027559Not ApplicableCompleted
fMRI Study of Treatment Changes in Major Depression
Major DepressionTreatment
Principalinvestigator

Research Network

Collaboration Network

61 collaborators·109 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yvette I Sheline, MD

University of Pennsylvania

Similar
3 trials

Shared therapeutic areas:

DepressionUnipolar DepressionDepressive Disorder+3 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)Washington University School of Medicine
Collaborated on 1 trial
Similarity Score64%

Mark George, MD

Medical University of South Carolina

Moderately Similar
6 trials

Shared therapeutic areas:

DepressionMajor Depressive DisorderDepressive Disorder, Treatment-Resistant

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score34%

Carlos A Zarate, M.D.

National Institute of Mental Health (NIMH)

Related
19 trials

Shared therapeutic areas:

DepressionMajor Depressive DisorderMajor Depression+3 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score23%

Yair bAR-hAIM, PhD

Tel Aviv University

Related
18 trials

Shared therapeutic areas:

DepressionUnipolar DepressionDepressive Disorder+1 more
Similarity Score15%

Leighton Y. Huey, MD

UConn Health

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score14%

Azfar Malik, MD

Psych Care Consultants Research

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score14%

Thomas Schwartz, MD

SUNY UMU at Syracuse

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score14%

Craig J Vine, MD

Psychiatric Recovery

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score14%

Greg Seal, MD

Louisiana Clinical Research, LLC

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score14%

Anthony Rothschild, MD

University of Massachusetts, Worcester

Related
2 trials

Shared therapeutic areas:

Major Depressive Disorder

Worked with same sponsors:

Cyberonics, Inc.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04753385PrincipalInvestigator

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Treatment Resistant Depression
Terminated
NCT03887715Not ApplicablePrincipalInvestigator

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Treatment Resistant Depression
Recruiting
NCT03537547Phase 4PrincipalInvestigator

Combinatorial Pharmacogenomics Testing in Treatment-NaĂ¯ve Major Depressive Disorder

DepressionDepression, UnipolarDepressive Disorder+2 more
Terminated
NCT02942368Phase 1PrincipalInvestigator

Adaptive tDCS for Treatment-Resistant MDD

Depressive Disorder, Treatment-Resistant
Terminated
NCT00320372PrincipalInvestigator

Treatment-Resistant Depression Registry

Major Depressive Disorder
Completed
NCT01027559Not ApplicablePrincipalInvestigator

fMRI Study of Treatment Changes in Major Depression

Major DepressionTreatment
Completed

All 6 trials loaded